PharmaCyte Biotech Releases Medical and Scientific Discussion from 2016 ASCO Annual Meeting Biotech Investing
Atara Bio Receives Advanced Therapy Medicinal Product Classification for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes (EBV-CTLs) from European Medicines Agency (EMA) Biotech Investing
RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors Biotech Investing
Seven Bridges Is Named to MIT Technology Review’s Annual 50 Smartest Companies List Biotech Investing
Agriculture Environmental Stewardship Act of 2016 Introduced in U.S. House to Create Tax Incentive for Investments in Biogas and Nutrient Recovery Agriculture Investing
Catalyst Biosciences Receives Patents Covering its Hemostasis and Anti-Complement Programs Biotech Investing
Adaptimmune Receives Positive Opinion for Orphan Drug Designation in the European Union for SPEAR™ T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma Biotech Investing
